Lutefeine
Natural health product licensed in Canada
- Other names
- America's Finest Inc Lutefeine, Lutefeine -Z, Sanutra Lutefeine, Sanutra Lutefeine - Z, Zealutein
- Licence holder
- Sabinsa Canada Inc.
- NPN or DIN-HM
- 80086454
- Status
- Active licence
- Licence date
- 20 June 2018
- Revision date
- 29 July 2025
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Tagetes erecta Source : Fleur Potency : 5 milligramme Lutein | Not specified | Not calculated |
Non-medicinal ingredients
Piperine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 2 days |
Uses authorised in Canada
Provides antioxidants for the maintenance of eye health. Helps to reduce the risk of developing cataracts. Helps to improve macular pigment - optical density. Helps to maintain eye sight in conditions (associated with sunlight damage) such as cataracts and age related macular degenerations. Helps to support eye health in conditions (associated with sunlight damage), such as cataracts and age related macular degenerations. Helps (temporarily) to promote alertness and wakefulness, and to enhance the cognitive performance. Helps (temporarily)to relieve fatigue, to promote endurance, and to enhance motor performance.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Do not use if you are allergic to plants of asteraceae/ compositae/ daisy family. Hypersensitivity / allergy is known to occur, in which case, discontinue use.
Source
Official Health Canada record, licence 80086454
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.